3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6807
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum ; volume:16 ; number:1 ; day:17 ; month:8 ; year:2016 ; pages:1-11 ; date:12.2016
BMC structural biology ; 16, Heft 1 (17.8.2016), 1-11, 12.2016
- Urheber
-
Kumari, Madhulata
- Beteiligte Personen und Organisationen
-
Chandra, Subhash
Tiwari, Neeraj
Subbarao, Naidu
SpringerLink (Online service)
- DOI
-
10.1186/s12900-016-0063-7
- URN
-
urn:nbn:de:1111-201609154000
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kumari, Madhulata
- Chandra, Subhash
- Tiwari, Neeraj
- Subbarao, Naidu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
CP-MLR directed QSAR study of carbonic anhydrase inhibitors: sulfonamide and sulfamate inhibitors
Development and characterisation of inhibitors of the E. coli methionine aminopeptidase
QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors
Investigation of BCRP-inhibitors using QSAR and machine learning methods
Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors
QSAR analysis on tacrine-related acetylcholinesterase inhibitors
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
CP-MLR directed QSAR study of carbonic anhydrase inhibitors: sulfonamide and sulfamate inhibitors
Development and characterisation of inhibitors of the E. coli methionine aminopeptidase
QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors
Investigation of BCRP-inhibitors using QSAR and machine learning methods
Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors
QSAR analysis on tacrine-related acetylcholinesterase inhibitors
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
CP-MLR directed QSAR study of carbonic anhydrase inhibitors: sulfonamide and sulfamate inhibitors
Development and characterisation of inhibitors of the E. coli methionine aminopeptidase
QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors
Investigation of BCRP-inhibitors using QSAR and machine learning methods
Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors
QSAR analysis on tacrine-related acetylcholinesterase inhibitors